Entrada Therapeutics TRDA
NASDAQ TRDA
$6.35 +0.09 (+1.44%)
At close: Sep 30, 2026 · 4:00 PM EDT

Entrada Therapeutics (TRDA) Shares Outstanding (Entity) (2020 - 2026)

Updated

Entrada Therapeutics' Shares Outstanding (Entity) was 38.94 million in Q2 2026, up 2.4% from 38.03 million a year earlier and up 0.3% from the prior quarter.

Analysis

Entrada Therapeutics (TRDA) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

For FY2025, Shares Outstanding (Entity) at Entrada Therapeutics came in at 38.28 million, up 1.9% from FY2024.

  • Shares Outstanding (Entity) has now increased for five consecutive years, with a five-year compound annual growth rate of 98.4% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 37.57 million in FY2024 (+12.4%), 33.44 million in FY2023 (+6.5%), 31.39 million in FY2022 (+400.9%) and 6.27 million in FY2021 (+403.8%).
  • The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2020.
  • Compared with a year earlier, Shares Outstanding (Entity) has increased for 15 straight quarters, with growth averaging 6.1% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 1.4% in Q1 2024 to 403.8% in Q4 2021.
  • Per Business Quant data, TRDA's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 38.82 million (Q1 2026), 38.28 million (Q4 2025) and 38.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Entrada Therapeutics 247.25 Mn 247.25 Mn - 38.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.94 Mn
Mar 31, 2026 38.82 Mn
Dec 31, 2025 38.28 Mn
Sep 30, 2025 38.22 Mn
Jun 30, 2025 38.03 Mn
Mar 31, 2025 37.94 Mn
Dec 31, 2024 37.57 Mn
Sep 30, 2024 37.40 Mn
Jun 30, 2024 37.17 Mn
Mar 31, 2024 33.60 Mn
Dec 31, 2023 33.44 Mn
Sep 30, 2023 33.34 Mn
Jun 30, 2023 33.21 Mn
Mar 31, 2023 33.13 Mn
Dec 31, 2022 31.39 Mn
Sep 30, 2022 31.33 Mn
Jun 30, 2022 31.28 Mn
Mar 31, 2022 31.26 Mn
Dec 31, 2021 6.27 Mn
Sep 30, 2021 1.48 Mn
API Access

Entrada Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TRDA&period=max&api_key=YOUR_API_KEY